All stock lists
Textron Inc. (New York Stock Exchange:TXT)
US · Delayed Price · Currency is USD
Also listed: 0LF0.LIndustrials · Aerospace & Defense
$84.12-$0.19 (-0.23%)
Market cap
$14.2B
Insider Score
Health Score
Analyst consensus
Listed since
Dec 22, 1947
Website
Insider Score
––Not scored
TXT Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From TXT’s reported statements · Q4 2026 (trailing 12 months)
Profitability13 / 20
Profitable, but on a thin margin.
- Revenue
- $15.45B
- Net income
- $973.0M
- Net margin
- 6.3%
Leverage14 / 20
A manageable debt load.
- Total debt
- $3.46B
- Cash
- $1.61B
- Net debt / EBITDA
- 1.12x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $7.39B
- Current liabilities
- $1.30B
- Current ratio
- 5.69
Cash generation14 / 20
The business funds itself from operations.
- Operating cash flow
- $1.31B
- Free cash flow
- $809.0M
- FCF margin
- 5.2%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 171.3M
- Share growth (1y)
- -4.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
TXT Income Statement
| Fiscal Period | Q4 2026 | Q2 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Oct 3, 2026 | Jun 30, 2026 | Apr 4, 2026 | Jan 3, 2026 | Sep 27, 2025 | Jun 28, 2025 |
| Revenue | $3.75 B | $3.83 B | $3.69 B | $4.17 B | $3.60 B | $3.72 B |
| Revenue Growth (YoY) | 4.14 % | 2.99 % | 11.77 % | 15.55 % | 5.11 % | 5.36 % |
| Cost of Revenue | $3.09 B | $3.13 B | $3.02 B | $3.67 B | $2.95 B | $3.01 B |
| Gross Profit | $665.00 M | $694.00 M | $672.00 M | $505.00 M | $654.00 M | $709.00 M |
| SG&A Expense | $271.00 M | $311.00 M | $321.00 M | $298.00 M | $257.00 M | $303.00 M |
| R&D Expense | $110.00 M | $116.00 M | $120.00 M | -$387.00 M | $118.00 M | $137.00 M |
| Operating Expenses | $413.00 M | $427.00 M | $441.00 M | $8.00 M | $375.00 M | $440.00 M |
| Operating Income | $252.00 M | $267.00 M | $231.00 M | $497.00 M | $279.00 M | $269.00 M |
| Pretax Income | $322.00 M | $304.00 M | $267.00 M | $279.00 M | $316.00 M | $301.00 M |
| Tax Provision | $52.00 M | $56.00 M | $47.00 M | $43.00 M | $81.00 M | $56.00 M |
| Net Income | $270.00 M | $248.00 M | $220.00 M | $235.00 M | $234.00 M | $245.00 M |
| EPS (Basic) | $1.58 | $1.43 | $1.25 | $1.31 | $1.31 | $1.36 |
| EPS (Diluted) | $1.56 | $1.42 | $1.25 | $1.32 | $1.31 | $1.35 |
| Shares Outstanding | 171.27 M | 171.94 M | 176.00 M | 180.26 M | 178.63 M | 178.16 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.